VR Logo

Paratek Pharmaceuticals Inc. (PRTK) download report


Healthcare | Biotechnology & Pharma Research

Paratek Pharmaceuticals Inc. (PRTK) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use.

IPO Date: 11-May-2006

Exec. Chairman: Mr. Michael F. Bigham CPA, CPA, M.B.A., MBA

CEO & Director: Dr. Evan Loh FACC, FAHA, M.D.

Listing: NASDAQ: PRTK

Country: United States

Headquarters: Boston, MA

Website: https://paratekpharma.com

Key Facts

Market cap: $112.23 Mln

Revenue (TTM): $136.50 Mln

Earnings (TTM): $-58.65 Mln

Cash: $79.05 Mln

Total Debt: $257.01 Mln

Insider's Holding: 16.58%

Liquidity: Low

52 Week range: $1.60 - 7.27

Shares outstanding: 54,478,500

10 Years Aggregate:

  • CFO: $-642.83 Mln
  • EBITDA: $-633.53 Mln
  • Net Profit: $-725.63 Mln

Stock Performance

Time Period Paratek Pharmaceuticals (PRTK) S&P BSE Sensex S&P Small-Cap 600
YTD-56.57-8.97-19.67
1 month4.28-3.38-9.84
3 months-35.22-7.93-15.05
1 Year-71.740.55-18.10
3 Years-21.2310.415.71
5 Years-40.1111.455.53
10 Years-28.1612.0510.04
As on 29-Jun-2022
Year Paratek Pharmaceuticals (PRTK) S&P Small-Cap 600 S&P BSE Sensex
2021-28.2725.2721.99
202055.339.5715.75
2019-21.4420.8614.38
2018-71.14-9.705.87
201716.2311.7327.91
2016-18.8224.741.95
2015-50.79-3.36-5.03